Illumina(ILMN.US)

Last Updated 19:00:00 ET
longbridge loading

Illumina Earnings Call Signals Confident Clinical Pivot

Tip Ranks·
US
ILMN
+0.12%
US
BBH
+0.68%
US
BIB
+0.05%
Tip Ranks·
US
ILMN
+0.12%
US
BBH
+0.68%
US
BIB
+0.05%

Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact | ILMN Stock News

StockTitan·
US
ILMN
+0.12%
US
FBT
+0.54%
US
LABU
-2.35%
StockTitan·
US
ILMN
+0.12%
US
FBT
+0.54%
US
LABU
-2.35%

10:30 ETCancer Biomarkers Market worth $54.48 billion by 2032 | MarketsandMarkets™

prnewswire·
US
RHHBY
+1.49%
US
TMO
+1.31%
US
ILMN
+0.12%
prnewswire·
US
RHHBY
+1.49%
US
TMO
+1.31%
US
ILMN
+0.12%

Illumina Inc. Stock Underperforms Thursday When Compared To Competitors

MarketWatch Automated·
US
ILMN
+0.12%
US
IBB
+0.10%
US
LABU
-2.35%
MarketWatch Automated·
US
ILMN
+0.12%
US
IBB
+0.10%
US
LABU
-2.35%

Assessing Illumina (ILMN) Valuation After Strong Recent Share Price Gains

Simplywall·
US
ILMN
+0.12%
US
SBIO
-1.24%
US
BIB
+0.05%
Simplywall·
US
ILMN
+0.12%
US
SBIO
-1.24%
US
BIB
+0.05%

The Bull Case For Illumina (ILMN) Could Change Following Upgraded 2026 Outlook And Major Buyback - Learn Why

Simplywall·
US
ILMN
+0.12%
US
LABU
-2.35%
US
SBIO
-1.24%
Simplywall·
US
ILMN
+0.12%
US
LABU
-2.35%
US
SBIO
-1.24%

Illumina Inc. Stock Outperforms Competitors On Strong Trading Day

MarketWatch Automated·
US
ILMN
+0.12%
US
IHI
+1.00%
MarketWatch Automated·
US
ILMN
+0.12%
US
IHI
+1.00%
© 2026 Longbridge｜Disclaimer